Ombitasvir/paritaprevir/ritonavir+dasabuvir+ribavirin for chronic hepatitis C virus genotype 1b-infected cirrhotics (TURQUOISE-IV)Isakov V.,
Paduta D.,
Viani R.M.,
Enejosa J.V.,
Pasechnikov V.,
Znoyko O.,
Ogurtsov P.,
Bogomolov P.O.,
Maevskaya M.V.,
Chen X.,
Shulman N.S. Objective An estimated 336 per 100 000 people in Russia are infected with
hepatitis C virus Development of methods and apporoaches for detection of intrahospital and indoor viral contamination of the
hepatitis A and
C viruses (HAV and HCV), as well as understanding how long time these
viruses can be stored
Cost-effectiveness of boceprevir in the combination therapy of hepatitis C virus infectionChronic infection caused by
hepatitis C virus (HCV) is one of the main causes of liver diseases
Immunopathogenesis of chronic hepatitis B immune cells. All events, including penetration of
hepatitis B
virus (HBV) particles into host cells
GENETIC DIVERSITY AND POSSIBLE ORIGINS OF THE HEPATITIS B VIRUS IN SIBERIAN NATIVESManuylov V.,
Chulanov Vladimir,
Bezuglova L.,
Chub E.,
Karlsen A.,
Kyuregyan K.,
Ostankova Y.,
Semenov A.,
Osipova L.,
Tallo T.,
Netesova I.,
Tkachuk A.,
Gushchin V.,
Netesov S.,
Magnius L.O.,
Norder Heléne A total of 381
hepatitis B
virus (HBV) DNA sequences collected from nine groups of Siberian native